LabGenomics USA Completes Acquisition of IMD CLIA Labs to Expand Diagnostic Services
Acquiring Company
LabGenomics USA
Acquired Company
Integrated Molecular Diagnostics (IMD) CLIA labs
RockvilleBerkeleyBiotechnologyHealth CareBiotechnologyHealth CareHealth DiagnosticsDescription
LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, expanding its diagnostic services nationwide, particularly in molecular technology. This acquisition strengthens LabGenomics’ strategic development and geographic reach, adding facilities in Berkeley, Sacramento, and Aurora.
Quick answer
LabGenomics USA is acquiring Integrated Molecular Diagnostics (IMD) CLIA labs, announced October 25, 2024. LabGenomics USA is based in Rockville, Maryland, United States.
- How much did LabGenomics USA pay for Integrated Molecular Diagnostics (IMD) CLIA labs?
- The deal value was not disclosed.
- What does LabGenomics USA do?
- LabGenomics USA is a leading provider of diagnostic services with a strategic development approach.
- Where are LabGenomics USA and Integrated Molecular Diagnostics (IMD) CLIA labs based?
- LabGenomics USA is based in Rockville, Maryland, United States. Integrated Molecular Diagnostics (IMD) CLIA labs is based in Berkeley, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Health Diagnostics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Access Genetics dba OralDNA® Labs acquires Breakthrough Point-of-Care Rapid PCR Technology from Sensible Diagnostics Inc. (October 22, 2024)
- XOMA Royalty Corporation acquires Pulmokine Inc. for $20 Million to add Seralutinib, a Phase 3 Asset, to its Portfolio, $20M (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Novartis acquires Kate Therapeutics to strengthen gene therapy portfolio (November 21, 2024)
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Flashpoint Therapeutics announces $50M Partnership with KAIMRC and Clinical Pipeline Expansion (November 14, 2024)
Who to call at LabGenomics USA, and when
When LabGenomics USA changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day LabGenomics USA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LabGenomics USA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LabGenomics USA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LabGenomics USA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Integrated Molecular Diagnostics (IMD) CLIA labs?
Integrated Molecular Diagnostics (IMD) CLIA labs was acquired by LabGenomics USA, based in Rockville. The deal was reported on October 25, 2024. LabGenomics USA is a leading provider of diagnostic services with a strategic development approach. LabGenomics USA is privately held and operates in Biotechnology.
When did LabGenomics USA acquire Integrated Molecular Diagnostics (IMD) CLIA labs?
LabGenomics USA's acquisition of Integrated Molecular Diagnostics (IMD) CLIA labs was reported on October 25, 2024. LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, expanding its diagnostic services nationwide, particularly in molecular technology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Integrated Molecular Diagnostics (IMD) CLIA labs do?
IMD Path is an Integrated Molecular Diagnostics Laboratory that enabling pathology and empowering oncology. We hold two operating facilities in Berkeley, CA and Denver, CO that offer state-of-the-art technology and testing capabilities. It is privately held, operating in Biotechnology, and is based in Berkeley.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.